ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,227Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 887

$383K Total Retail Price of All Prescriptions

Rank: 74 out of 887

465 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 465 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.

Schedule Three
Controlled Substances

6% of this provider’s 465 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 5,965 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 392 295 1 3
AMLODIPINE BESYLATE 347 228 2 5
HYDROCHLOROTHIAZIDE 295 216 3 10
FUROSEMIDE 287 245 4 7
METFORMIN HCL 246 186 5 8
PRAVASTATIN SODIUM 183 132 6 12
LISINOPRIL 164 119 7 4
GLIMEPIRIDE 154 122 8 54
METOPROLOL TARTRATE 145 118 9 16
DIOVAN HCT 143 91 10 94
ALLOPURINOL 141 108 11 66
BENAZEPRIL HCL 135 72 12 84
VERAPAMIL ER 131 84 13 153
OMEPRAZOLE 128 85 14 2
METOPROLOL SUCCINATE 127 115 15 19
POTASSIUM CHLORIDE 119 100 16 21
LEVOTHYROXINE SODIUM 116 74 17 9
CRESTOR 115 98 18 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 70 19 22
BENAZEPRIL-HYDROCHLOROTHIAZIDE 103 103 20 178
TRAMADOL HCL 98 53 21 15
ATORVASTATIN CALCIUM 95 49 22 13
AMLODIPINE BESYLATE-BENAZEPRIL 87 67 23 63
NEXIUM 83 50 24 18
GABAPENTIN 81 58 25 6
POLYETHYLENE GLYCOL 3350 78 71 26 67
RANITIDINE HCL 72 58 27 59
ZOLPIDEM TARTRATE 70 50 28 14
DIOVAN 70 36 28 81
AMITRIPTYLINE HCL 69 37 R 30 70
CLOPIDOGREL 68 53 31 46
ACTOS 67 55 32 101
WARFARIN SODIUM 67 56 32 26
LOSARTAN POTASSIUM 64 35 34 42
LOSARTAN-HYDROCHLOROTHIAZIDE 64 37 34 68
DONEPEZIL HCL 64 64 34 51
PANTOPRAZOLE SODIUM 63 50 37 47
KLOR-CON M20 63 40 37 127
FLUTICASONE PROPIONATE 56 38 39 29
PROAIR HFA 54 19 40 39
NAPROXEN 53 29 41 99
LANTUS 53 51 41 97
CYCLOBENZAPRINE HCL 53 29 R 41 35
PREDNISONE 51 38 44 30
TRIAMTERENE-HCTZ 51 39 44 115
HYDROCODONE-ACETAMINOPHEN 51 40 S3 44 1
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.